Explore our Microsites

Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.

Peter Schlueter Photo

Peter J. Schlueter, Ph.D.



Peter applies an extensive scientific background and Ph.D. in Molecular, Cellular, and Developmental Biology to his intellectual property practice. With 10 years of experience as a research scientist, he is uniquely situated to counsel clients in the intersecting spaces of intellectual property and the life sciences.  

Peter provides strategic guidance to clients regarding the development and management their patent portfolios, from strategy and prosecution to litigation support and licensing. He also counsels clients on transactional matters related to intellectual property and FDA regulatory compliance.

Peter works with clients across industries, including the fields of:

  • Small molecule drug development
  • Pharmaceuticals and biologics
  • Medical devices and biosensing systems
  • Transgenic plant and animal technology
  • Agricultural chemicals and products

Prior to attending law school, Peter earned his Ph.D. from the University of Michigan, where his research focused on elucidating the molecular mechanisms that underlie insulin-like growth factor (IGF) signaling. As a postdoctoral fellow at the Harvard Medical School, Peter’s research focused on phenotype-based drug discovery using high-throughput small molecule screens.

In addition to having published several research papers and review articles, Peter has taught courses at the University of Michigan and the Woods Hole Oceanographic Institute.


  • Inventor, Allowed U.S. Patent Application No. 14/206,135, entitled “Novel Germ Cell Ablation Compounds and Uses Thereof”
  • Managed patent portfolio of a biosensor startup that had been transferred from another firm, obtaining allowances of the majority of the company’s patents within one year. Peter’s portfolio guidance allowed the client to begin the process of being acquired by a larger company.
  • Performed an ex parte reexamination and accompanying opposition proceeding in Europe for a client’s key therapeutic fusion protein patent
  • Performed patent prosecution and agreement work for an agricultural company during its formation as a joint venture of two separate spinoffs of larger agricultural companies



Community Involvement

  • Member, Board of Directors, ReSpectacle, Inc., 2012-present
back to top